D.E. Shaw & Co’s Amgen AMGN Stock Holding History

D.E. Shaw & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.3M	Buy	17,900 +3,900	+28%	+$1.39M	﹤0.01%	2002
2025 Q4	$4.58M	Sell	14,000 -8,000	-36%	-$2.54M	﹤0.01%	2381
2025 Q3	$6.21M	Sell	22,000 -2,000	-8%	-$580K	﹤0.01%	2024
2025 Q2	$6.7M	Sell	24,000 -147,500	-86%	-$41.8M	﹤0.01%	1802
2025 Q1	$53.4M	Sell	171,500 -4,500	-3%	-$1.33M	0.05%	453
2024 Q4	$45.9M	Buy	176,000 +123,500	+235%	+$36.6M	0.03%	606
2024 Q3	$16.9M	Buy	52,500 +1,500	+3%	+$491K	0.01%	1100
2024 Q2	$15.9M	Sell	51,000 -34,500	-40%	-$10.1M	0.01%	1037
2024 Q1	$24.3M	Buy	85,500 +23,000	+37%	+$6.73M	0.02%	815
2023 Q4	$18M	Buy	62,500 +20,000	+47%	+$5.45M	0.02%	997
2023 Q3	$11.4M	Buy	42,500 +20,000	+89%	+$4.99M	0.01%	1205
2023 Q2	$5M	Sell	22,500 -27,500	-55%	-$6.38M	0.01%	1859
2023 Q1	$12.1M	Buy	+50,000	New	+$12.3M	0.01%	1220
2022 Q4	–	Sell	-47,500	Closed	-$10.7M	–	4839
2022 Q3	$10.7M	Sell	47,500 -90,000	-65%	-$21.8M	0.01%	1294
2022 Q2	$33.5M	Buy	137,500 +57,500	+72%	+$14.1M	0.04%	582
2022 Q1	$19.3M	Buy	80,000 +5,200	+7%	+$1.19M	0.02%	1051
2021 Q4	$16.8M	Sell	74,800 -24,100	-24%	-$5.09M	0.01%	1219
2021 Q3	$21M	Buy	98,900 +52,600	+114%	+$12.1M	0.02%	991
2021 Q2	$11.3M	Sell	46,300 -13,700	-23%	-$3.37M	0.01%	1394
2021 Q1	$14.9M	Buy	60,000 +6,500	+12%	+$1.55M	0.01%	1115
2020 Q4	$12.3M	Buy	53,500 +43,500	+435%	+$10M	0.01%	1248
2020 Q3	$2.54M	Sell	10,000 -20,000	-67%	-$4.95M	﹤0.01%	2214
2020 Q2	$7.08M	Sell	30,000 -22,500	-43%	-$5.13M	0.01%	1406
2020 Q1	$10.6M	Buy	52,500 +10,500	+25%	+$2.29M	0.02%	959
2019 Q4	$10.1M	Sell	42,000 -29,300	-41%	-$6.46M	0.01%	1201
2019 Q3	$13.8M	Sell	71,300 -28,000	-28%	-$5.37M	0.02%	972
2019 Q2	$18.3M	Buy	+99,300	New	+$17.8M	0.02%	794
2018 Q4	–	Sell	-4,100	Closed	-$850K	–	3734
2018 Q3	$850K	Sell	4,100 -12,600	-75%	-$2.48M	﹤0.01%	2787
2018 Q2	$3.08M	Buy	16,700 +3,300	+25%	+$584K	﹤0.01%	1904
2018 Q1	$2.28M	Sell	13,400 -205,300	-94%	-$37.7M	﹤0.01%	1961
2017 Q4	$38M	Buy	218,700 +26,800	+14%	+$4.74M	0.05%	430
2017 Q3	$35.8M	Buy	191,900 +28,800	+18%	+$5.1M	0.06%	414
2017 Q2	$28.1M	Sell	163,100 -22,800	-12%	-$3.71M	0.05%	467
2017 Q1	$30.5M	Sell	185,900 -4,200	-2%	-$698K	0.05%	414
2016 Q4	$27.8M	Buy	190,100 +74,700	+65%	+$11.2M	0.05%	495
2016 Q3	$19.3M	Buy	115,400 +20,700	+22%	+$3.5M	0.03%	593
2016 Q2	$14.4M	Sell	94,700 -24,900	-21%	-$3.87M	0.03%	686
2016 Q1	$17.9M	Sell	119,600 -138,300	-54%	-$20.5M	0.03%	585
2015 Q4	$41.9M	Buy	257,900 +56,500	+28%	+$8.88M	0.06%	364
2015 Q3	$27.9M	Buy	201,400 +83,400	+71%	+$13.1M	0.04%	495
2015 Q2	$18.1M	Sell	118,000 -205,200	-63%	-$32.9M	0.03%	672
2015 Q1	$51.7M	Sell	323,200 -492,000	-60%	-$77.5M	0.08%	290
2014 Q4	$130M	Buy	815,200 +125,100	+18%	+$19.5M	0.17%	117
2014 Q3	$96.9M	Buy	690,100 +215,500	+45%	+$28.1M	0.13%	174
2014 Q2	$56.2M	Buy	474,600 +24,100	+5%	+$2.79M	0.08%	298
2014 Q1	$55.6M	Buy	450,500 +140,000	+45%	+$17M	0.08%	274
2013 Q4	$35.4M	Sell	310,500 -700	-0.2%	-$79.6K	0.05%	429
2013 Q3	$34.8M	Buy	311,200 +41,000	+15%	+$4.45M	0.06%	372
2013 Q2	$26.7M	Buy	+270,200	New	+$28M	0.05%	416

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co's AMGN Position: Q1 2026 in Review

D.E. Shaw & Co increased its Amgen (AMGN) stake by 514% in Q1 2026, buying an estimated $53.1M and bringing the position to 178,009 shares worth $62.6M. The position accounts for 0.04% of the portfolio, ranked #569.

D.E. Shaw & Co first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $515M in Q4 2024. 3,125 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

D.E. Shaw & Co held 178,009 shares of Amgen worth $62.6M as of Q1 2026.
D.E. Shaw & Co bought 149,032 Amgen shares in Q1 2026, an estimated $53.1M.
Amgen made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #569 holding.
D.E. Shaw & Co first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
D.E. Shaw & Co's Amgen position peaked at $515M in Q4 2024.
3,125 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.